145 related articles for article (PubMed ID: 22309084)
21. Prostaglandin J2 metabolites inhibit aromatase activity by redox-sensitive mechanisms: potential implications for breast cancer therapy.
Winnett G; van Hagen D; Schrey M
Int J Cancer; 2003 Feb; 103(5):600-5. PubMed ID: 12494466
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
Grau R; Iñiguez MA; Fresno M
Cancer Res; 2004 Aug; 64(15):5162-71. PubMed ID: 15289320
[TBL] [Abstract][Full Text] [Related]
23. 15-Deoxy-Delta12,14-prostaglandin J2 induces COX-2 expression through Akt-driven AP-1 activation in human breast cancer cells: a potential role of ROS.
Kim EH; Na HK; Kim DH; Park SA; Kim HN; Song NY; Surh YJ
Carcinogenesis; 2008 Apr; 29(4):688-95. PubMed ID: 18192694
[TBL] [Abstract][Full Text] [Related]
24. 15d-prostaglandin J2 inhibits inflammatory hypernociception: involvement of peripheral opioid receptor.
Napimoga MH; Souza GR; Cunha TM; Ferrari LF; Clemente-Napimoga JT; Parada CA; Verri WA; Cunha FQ; Ferreira SH
J Pharmacol Exp Ther; 2008 Jan; 324(1):313-21. PubMed ID: 17928570
[TBL] [Abstract][Full Text] [Related]
25. 15-deoxy-Delta12,14-prostaglandin J2 as a potential endogenous regulator of redox-sensitive transcription factors.
Kim EH; Surh YJ
Biochem Pharmacol; 2006 Nov; 72(11):1516-28. PubMed ID: 16987499
[TBL] [Abstract][Full Text] [Related]
26. 15-deoxy-Delta12,14-prostaglandin J2 inhibits INF-gamma-induced JAK/STAT1 signalling pathway activation and IP-10/CXCL10 expression in mesangial cells.
Panzer U; Zahner G; Wienberg U; Steinmetz OM; Peters A; Turner JE; Paust HJ; Wolf G; Stahl RA; Schneider A
Nephrol Dial Transplant; 2008 Dec; 23(12):3776-85. PubMed ID: 18596134
[TBL] [Abstract][Full Text] [Related]
27. An endogenous electrophile that modulates the regulatory mechanism of protein turnover: inhibitory effects of 15-deoxy-Delta 12,14-prostaglandin J2 on proteasome.
Shibata T; Yamada T; Kondo M; Tanahashi N; Tanaka K; Nakamura H; Masutani H; Yodoi J; Uchida K
Biochemistry; 2003 Dec; 42(47):13960-8. PubMed ID: 14636064
[TBL] [Abstract][Full Text] [Related]
28. The cyclopentenone-type prostaglandin 15-deoxy-delta 12,14-prostaglandin J2 inhibits CD95 ligand gene expression in T lymphocytes: interference with promoter activation via peroxisome proliferator-activated receptor-gamma-independent mechanisms.
Cippitelli M; Fionda C; Di Bona D; Lupo A; Piccoli M; Frati L; Santoni A
J Immunol; 2003 May; 170(9):4578-92. PubMed ID: 12707336
[TBL] [Abstract][Full Text] [Related]
29. Selective inhibition of cyclooxygenase-2 expression by 15-deoxy-Delta(12,14)(12,14)-prostaglandin J(2) in activated human astrocytes, but not in human brain macrophages.
Janabi N
J Immunol; 2002 May; 168(9):4747-55. PubMed ID: 11971025
[TBL] [Abstract][Full Text] [Related]
30. 15-Deoxy-Delta(12,14)-prostaglandin J(2) rescues PC12 cells from H2O2-induced apoptosis through Nrf2-mediated upregulation of heme oxygenase-1: potential roles of Akt and ERK1/2.
Kim JW; Li MH; Jang JH; Na HK; Song NY; Lee C; Johnson JA; Surh YJ
Biochem Pharmacol; 2008 Dec; 76(11):1577-89. PubMed ID: 18775681
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of trail gene expression by cyclopentenonic prostaglandin 15-deoxy-delta12,14-prostaglandin J2 in T lymphocytes.
Fionda C; Nappi F; Piccoli M; Frati L; Santoni A; Cippitelli M
Mol Pharmacol; 2007 Nov; 72(5):1246-57. PubMed ID: 17673570
[TBL] [Abstract][Full Text] [Related]
32. 15-Deoxy-Δ12,14-prostaglandin J2 induces Cox-2 expression in human osteosarcoma cells through MAPK and EGFR activation involving reactive oxygen species.
Kitz K; Windischhofer W; Leis HJ; Huber E; Kollroser M; Malle E
Free Radic Biol Med; 2011 Apr; 50(7):854-65. PubMed ID: 21236332
[TBL] [Abstract][Full Text] [Related]
33. The cyclopentenone prostaglandin 15-deoxy-Delta(12,14)-prostaglandin J(2) attenuates the development of acute and chronic inflammation.
Cuzzocrea S; Wayman NS; Mazzon E; Dugo L; Di Paola R; Serraino I; Britti D; Chatterjee PK; Caputi AP; Thiemermann C
Mol Pharmacol; 2002 May; 61(5):997-1007. PubMed ID: 11961117
[TBL] [Abstract][Full Text] [Related]
34. Protective effects of 15-deoxy-Delta12,14-prostaglandin J2 against glutamate-induced cell death in primary cortical neuron cultures: induction of adaptive response and enhancement of cell tolerance primarily through up-regulation of cellular glutathione.
Saito Y; Nishio K; Numakawa Y; Ogawa Y; Yoshida Y; Noguchi N; Niki E
J Neurochem; 2007 Sep; 102(5):1625-1634. PubMed ID: 17697048
[TBL] [Abstract][Full Text] [Related]
35. 15-deoxy-Delta12,14-prostaglandin J2 inhibits glucocorticoid binding and signaling in macrophages through a peroxisome proliferator-activated receptor gamma-independent process.
Cheron A; Peltier J; Perez J; Bellocq A; Fouqueray B; Baud L
J Immunol; 2004 Jun; 172(12):7677-83. PubMed ID: 15187150
[TBL] [Abstract][Full Text] [Related]
36. The 15-deoxy-δ12,14-prostaglandin J2 inhibits LPS‑stimulated inflammation via enhancement of the platelet‑activating factor acetylhydrolase activity in human retinal pigment epithelial cells.
Jung WK; Lee CM; Lee DS; Na G; Lee DY; Choi I; Park SG; Seo SK; Yang JW; Choi JS; Lee YM; Park WS; Choi IW
Int J Mol Med; 2014 Feb; 33(2):449-56. PubMed ID: 24337644
[TBL] [Abstract][Full Text] [Related]
37. 15-Deoxy-Delta(12,14)-prostaglandin J(2): the endogenous electrophile that induces neuronal apoptosis.
Kondo M; Shibata T; Kumagai T; Osawa T; Shibata N; Kobayashi M; Sasaki S; Iwata M; Noguchi N; Uchida K
Proc Natl Acad Sci U S A; 2002 May; 99(11):7367-72. PubMed ID: 12032289
[TBL] [Abstract][Full Text] [Related]
38. Translational regulation of cyclin D1 by 15-deoxy-delta(12,14)-prostaglandin J(2).
Campo PA; Das S; Hsiang CH; Bui T; Samuel CE; Straus DS
Cell Growth Differ; 2002 Sep; 13(9):409-20. PubMed ID: 12354750
[TBL] [Abstract][Full Text] [Related]
39. 15-Deoxy-Delta 12,14-prostaglandin J2 inhibition of NF-kappaB-DNA binding through covalent modification of the p50 subunit.
Cernuda-Morollón E; Pineda-Molina E; Cañada FJ; Pérez-Sala D
J Biol Chem; 2001 Sep; 276(38):35530-6. PubMed ID: 11466314
[TBL] [Abstract][Full Text] [Related]
40. Streptozotocin-pancreatic damage in the rat: modulatory effect of 15-deoxy delta12,14-prostaglandin j(2) on nitridergic and prostanoid pathway.
González E; Jawerbaum A; Sinner D; Pustovrh C; White V; Capobianco E; Xaus C; Peralta C; Roselló-Catafau J
Nitric Oxide; 2002 Mar; 6(2):214-20. PubMed ID: 11890746
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
